MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 117 filers reported holding MIRUM PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,778 | +22.2% | 436 | 0.0% | 0.00% | – |
| Q2 2023 | $11,279 | +7.7% | 436 | 0.0% | 0.00% | – |
| Q1 2023 | $10,473 | +34.3% | 436 | +9.0% | 0.00% | – |
| Q4 2022 | $7,800 | -2.5% | 400 | 0.0% | 0.00% | – |
| Q3 2022 | $8,000 | 0.0% | 400 | 0.0% | 0.00% | – |
| Q2 2022 | $8,000 | -11.1% | 400 | 0.0% | 0.00% | – |
| Q1 2022 | $9,000 | +50.0% | 400 | 0.0% | 0.00% | – |
| Q4 2021 | $6,000 | -68.4% | 400 | -58.0% | 0.00% | -100.0% |
| Q3 2021 | $19,000 | +18.8% | 953 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $16,000 | +100.0% | 953 | +138.2% | 0.00% | – |
| Q1 2021 | $8,000 | +14.3% | 400 | 0.0% | 0.00% | – |
| Q4 2020 | $7,000 | -12.5% | 400 | 0.0% | 0.00% | – |
| Q3 2020 | $8,000 | +14.3% | 400 | 0.0% | 0.00% | – |
| Q2 2020 | $7,000 | +40.0% | 400 | 0.0% | 0.00% | – |
| Q1 2020 | $5,000 | -50.0% | 400 | 0.0% | 0.00% | -100.0% |
| Q4 2019 | $10,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 6,470,392 | $204,464,387 | 13.58% |
| NEA Management Company, LLC | 2,186,243 | $69,085,279 | 5.34% |
| TANG CAPITAL MANAGEMENT LLC | 1,137,107 | $35,932,581 | 5.07% |
| BOONE CAPITAL MANAGEMENT LLC | 389,791 | $12,317,396 | 3.89% |
| Highlander Partners, L.P. | 122,980 | $3,886,168 | 3.84% |
| BVF INC/IL | 4,370,024 | $138,092,758 | 3.72% |
| Prosight Management, LP | 353,508 | $11,170,853 | 3.54% |
| Novo Holdings A/S | 1,500,000 | $47,400,000 | 3.50% |
| Nicholas Investment Partners, LP | 1,199,366 | $37,899,966 | 2.83% |
| Eventide Asset Management | 3,958,579 | $125,091,097 | 2.25% |